Cite

HARVARD Citation

    Sekulic, A. et al. (n.d.). Personalized treatment of Sézary syndrome by targeting a novel CTLA4:CD28 fusion. Molecular genetics & genomic medicine. 3 (2), pp. 130-136. [Online]. 
  
Back to record